Recent IPOs show investor appetite is strong for biotechs...
Investor appetite is strong for biotechs. Adaptive Biotechnologies ADPT is up on its second day of trading, after soaring more than 95% yesterday. The Seattle-b...
Investor appetite is strong for biotechs. Adaptive Biotechnologies ADPT is up on its second day of trading, after soaring more than 95% yesterday. The Seattle-b...